Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Drug Type (Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies and Cancer Vaccines, Others), By Service Type, By Cancer Type (Lung, Breast, Colorectal, Melanoma, Prostate, Head and Neck, Ovarian, Pancreatic), Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 – 2027.
Global Cancer Immunotherapy Drug Discovery Outsourcing Market
Global Cancer Immunotherapy Drug Discovery Outsourcing Market was valued at USD 1.2 billion in 2021 and it is expected to reach USD 2.6 billion, at a CAGR 10.2% from 2022-2027.
Qualiket Research has recently published a new report, titled Global Cancer Immunotherapy Drug Discovery Outsourcing Market Insights, Forecast to 2022-2027. The report has been put together using primary & secondary research methodologies, which offer an accurate & precise understanding of the Cancer Immunotherapy Drug Discovery Outsourcing market. Analysts have used a top-down & bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Cancer Immunotherapy Drug Discovery Outsourcing market. The report offers an overview of the market, which briefly describes the market condition as well as the leading segments. It also mentions the key players present in the global Cancer Immunotherapy Drug Discovery Outsourcing market.
The research report on the global Cancer Immunotherapy Drug Discovery Outsourcing market includes a SWOT analysis and Porter's five forces analysis, which help in providing the precise trajectory of the Cancer Immunotherapy Drug Discovery Outsourcing market. These market measurement tools help in identifying drivers, restraints, challenges, Cancer Immunotherapy Drug Discovery Outsourcing market opportunities, and threats. The research report offers global market figures as well as figures for regional markets & segments therein.
The Cancer Immunotherapy Drug Discovery Outsourcing research report opens with an executive summary that gives a brief overview of the market. It mentions the leading segments & the players that are expected to shape the market in the coming years. The report also sheds light on the restraints present in the global Cancer Immunotherapy Drug Discovery Outsourcing market. Analysts have discussed the details highlighting the factors which are expected to hamper the growth of the market in the coming years.
Cancer Immunotherapy Drug Discovery Outsourcing Market Competitive Landscape
The last chapter of the research report on the global Cancer Immunotherapy Drug Discovery Outsourcing market focuses on the key players & the competitive landscape present in the market. The report includes a list of strategic initiatives taken by the companies in recent years along with the ones which are expected to happen in the foreseeable future. Researchers have made a note of the financial outlook of these companies, their research & development activities, and their expansion plans for the near future.
Cancer Immunotherapy Drug Discovery Outsourcing Market Leading Players
Covance, Inc.; Explicyte; Aquila BioMedical; Horizon Discovery Group PLC; Crown Bioscience, Inc.; Promega Corporation; HD Biosciences Co., Ltd.; BPS Bioscience, Inc.; Genscript Biotech Corporation; DiscoverX Corporation., etc.
Market Taxonomy
By Service Type
Target Identification and Validation
Lead Screening and Characterization
Cell-based Assays
By Drug Type
Monoclonal Antibodies
Immunomodulators
Oncolytic Viral Therapies and Cancer Vaccines
Others
By Cancer Type
Lung
Breast
Colorectal
Melanoma
Prostate
Head and Neck
Ovarian
Pancreatic
By Region
North America
Latin America
Europe
Asia Pacific
Middle East & Africa
- 1 Introduction
- 1.1 Objective of the Study
- 1.2 Market definition
- 1.3 Market Scope
- 2 Research Methodology
- 2.1 Data Mining
- 2.2 Validation
- 2.3 Primary Interviews
- 2.4 List of Data Sources
- 3 Executive Summary
- 4 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
- 4.1 Overview
- 4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
- 4.3 Porters Five Force Model
- 4.4 Value Chain Analysis
- 5 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Drug Type
- 5.1 Y-o-Y Growth Comparison, By Drug Type
- 5.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share Analysis, By Drug Type
- 5.3 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Drug Type
- 5.3.1 Monoclonal Antibodies
- 5.3.2 Immunomodulators
- 5.3.3 Oncolytic Viral Therapies and Cancer Vaccines
- 5.3.4 Others
- 6 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Service Type
- 6.1 Y-o-Y Growth Comparison, By Service Type
- 6.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share Analysis, By Service Type
- 6.3 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Service Type
- 6.3.1 Target Identification and Validation
- 6.3.2 Lead Screening and Characterization
- 6.3.3 Cell-based Assays
- 7 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cancer Type
- 7.1 Y-o-Y Growth Comparison, By Cancer Type
- 7.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share Analysis, By Cancer Type
- 7.3 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Cancer Type
- 7.3.1 Lung
- 7.3.2 Breast
- 7.3.3 Colorectal
- 7.3.4 Melanoma
- 7.3.5 Prostate
- 7.3.6 Head and Neck
- 7.3.7 Ovarian
- 7.3.8 Pancreatic
- 8 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Region
- 8.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share Analysis, By Region
- 8.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share Analysis, By Region
- 8.3 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Region
- 9 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis and Forecast (2021-2027)
- 9.1 Introduction
- 9.2 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Share Analysis, By Drug Type
- 9.3 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Service Type
- 9.4 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Cancer Type
- 9.6 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Country
- 9.7.1 U.S.
- 9.7.2 Canada
- 9.7.3 Mexico
- 10 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis and Forecast (2021-2027)
- 10.1 Introduction
- 10.2 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Share Analysis, By Drug Type
- 10.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Service Type
- 10.4 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Cancer Type
- 10.6 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Country
- 10.6.1 Germany
- 10.6.2 France
- 10.6.3 UK
- 10.6.4. Rest of Europe
- 11 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis and Forecast (2021-2027)
- 11.1 Introduction
- 11.2 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Share Analysis, By Drug Type
- 11.3 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Service Type
- 11.4 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Cancer Type
- 11.6 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Country
- 11.6.1 China
- 11.7.2 Japan
- 11.8.3 India
- 11.8.4. Rest of Asia Pacific
- 12 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis and Forecast (2021-2027)
- 12.1 Introduction
- 12.2 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Share Analysis, By Drug Type
- 12.3 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Service Type
- 12.4 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Cancer Type
- 12.6 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, Country
- 12.7.1. Brazil
- 12.8.2. Rest of Latin America
- 13 Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis and Forecast (2021-2027)
- 13.1 Introduction
- 13.2 Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market Share Analysis, By Drug Type
- 13.3 Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Service Type
- 13.4 Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Cancer Type
- 13.6 Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Country
- 13.7.1. Saudi Arabia
- 13.8.2. UAE
- 13.8.3. Egypt
- 13.9.4. Kuwait
- 13.10.5. South Africa
- 14 Competitive Analysis
- 14.1 Competition Dashboard
- 14.2 Market share Analysis of Top Vendors
- 14.3 Key Development Strategies
- 15 Company Profiles
- 15.1 Covance, Inc
- 15.1.1 Overview
- 15.1.2 Drug Types
- 15.1.3 Key Financials
- 15.1.4 Business Segment & Geographic Overview
- 15.1.5 Key Market Developments
- 15.1.6 Key Strategies
- 15.2. Explicyte
- 15.2.1 Overview
- 15.2.2 Drug Types
- 15.2.3 Key Financials
- 15.2.4 Business Segment & Geographic Overview
- 15.2.5 Key Market Developments
- 15.2.6 Key Strategies
- 15.3. Aquila BioMedical
- 15.3.1 Overview
- 15.3.2 Drug Types
- 15.3.3 Key Financials
- 15.3.4 Business Segment & Geographic Overview
- 15.3.5 Key Market Developments
- 15.3.6 Key Strategies
- 15.4 Horizon Discovery Group PLC
- 15.4.1 Overview
- 15.4.2 Drug Types
- 15.4.3 Key Financials
- 15.4.4 Business Segment & Geographic Overview
- 15.4.5 Key Market Developments
- 15.4.6 Key Strategies
- 15.5 Crown Bioscience, Inc
- 15.5.1 Overview
- 15.5.2 Drug Types
- 15.5.3 Key Financials
- 15.5.4 Business Segment & Geographic Overview
- 15.5.5 Key Market Developments
- 15.5.6 Key Strategies
- 15.6 Promega Corporation
- 15.6.1 Overview
- 15.6.2 Drug Types
- 15.6.3 Key Financials
- 15.6.4 Business Segment & Geographic Overview
- 15.6.5 Key Market Developments
- 15.6.6 Key Strategies
- 15.7 HD Biosciences Co., Ltd
- 15.7.1 Overview
- 15.7.2 Drug Types
- 15.7.3 Key Financials
- 15.7.4 Business Segment & Geographic Overview
- 15.7.5 Key Market Developments
- 15.7.6 Key Strategies
- 15.8 BPS Bioscience, Inc
- 15.8.1 Overview
- 15.8.2 Drug Types
- 15.8.3 Key Financials
- 15.8.4 Business Segment & Geographic Overview
- 15.8.5 Key Market Developments
- 15.8.6 Key Strategies
- 15.9 Genscript Biotech Corporation
- 15.9.1 Overview
- 15.9.2 Drug Types
- 15.9.3 Key Financials
- 15.9.4 Business Segment & Geographic Overview
- 15.9.5 Key Market Developments
- 15.9.6 Key Strategies
- 15.10 DiscoverX Corporation
- 15.10.1 Overview
- 15.10.2 Drug Types
- 15.10.3 Key Financials
- 15.10.4 Business Segment & Geographic Overview
- 15.10.5 Key Market Developments
- 15.10.6 Key Strategies
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook